< Back to previous page
Researcher
Els Van Valckenborgh
- Keywords:Medicine
Affiliations
- Faculty of Medicine and Pharmacy (Faculty)
Member
From22 Jun 2017 → 7 Sep 2017 - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 30 Sep 2018 - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 30 Sep 2017 - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 30 Sep 2017 - Immunology and Microbiology (Department)
Member
From1 Feb 2012 → 31 Dec 2013 - Hematology (Research group)
Member
From1 Oct 2000 → 31 Dec 2014 - Immunology and Microbiology (Department)
Member
From1 Aug 2000 → 31 Dec 2013
Projects
1 - 5 of 5
- A study to target tumor-associated macrophages in multiple myeloma.From1 Jan 2016 → 31 Dec 2016Funding: FWO research grant KAN
- Drug resistance in multiple myeloma: study of extrinsic mechanisms governed by the bone marrow microenvironmentFrom1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- Study of resistance mechanisms in multiple myelomaFrom1 Jan 2013 → 31 Dec 2013Funding: FWO research grant KAN
- The interest of aldehyde dehydrogenase positive cells in the evolution of multiple myelomaFrom1 Jan 2011 → 31 Dec 2011Funding: FWO research grant KAN
- Identification and characterisation of the cancer stem cell in multiple myelomaFrom1 Jan 2009 → 31 Dec 2009Funding: FWO research grant KAN
Publications
31 - 40 of 75
- Epigenetic modulating agents as a new therapeutic approach in Multiple Myeloma(2013)
Authors: E Van Valckenborgh
Pages: 430-461 - The IGF-1 receptor inhbitor picropodophyllin (PPP) potentiates the anti-myeloma effects of the BH3 mimetic ABT-737.(2013)
Authors: Liesbeth Bieghs, E Van Valckenborgh, Martin Overgaard, He Johnsen, Mette Nyegaard, Karel Fostier, O. Larsson, Helena Jernberg-Wiklund
Pages: 26-26 - Nanobodies as new imaging tools in multiple myeloma: a study in the 5T2MM murine model.(2013)
Authors: Miguel Lemaire, E Van Valckenborgh, Nick Devoogdt
Pages: 14-14 - The generation and activation of myeloid-derived suppressor cells in multiple myeloma.(2013)
Authors: E Van Valckenborgh
Pages: 28-28 - The role of Notch signaling in multiple myeloma(2013)
Authors: Dehui Xu, Jinsong Hu, E Van Valckenborgh
Pages: 77-95Number of pages: 19 - Epigenetic modulation of myeloma within its bone marrow microenvironment(2013)Volume: 1
Authors: Sarah Deleu, E Van Valckenborgh, Isabelle Vande Broek, Joanna Fraczek, Helena Jernberg-Wiklund
Pages: 255-282Number of pages: 28 - The role of invariant natural killer T cells in cancer(2013)
Authors: Haneen Nur, E Van Valckenborgh
Pages: 44-71 - Dll1/Notch Interaction Contributes to a Decreased Sensitivity of Myeloma Cells to Bortezomib(2012)
Authors: Dehui Xu, Jinsong Hu, E Van Valckenborgh
Pages: 1840-1840 - Combination of the IGF-1 Receptor Inhibitor Picropodophylin and the BH3 Mimetic ABT-737 Has Synergistic Anti-Myeloma Activity(2012)
Authors: Liesbeth Bieghs, E Van Valckenborgh, He Johnsen, Mette Nyegaard, Helena Jernberg-Wiklund
Pages: 4010-4010 - Preclinical Evaluation of Invariant Natural Killer T-Cells in the 5T33 Multiple Myeloma Model(2012)
Authors: Haneen Nur, Sandrine Aspeslagh, E Van Valckenborgh, Dirk Elewaut
Pages: 938-938